Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400867 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections
A Phase 2 study of Infections, Pediatrics, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 163
- Enrollment target
- 20
- Study locations
NCT01400867 is a Phase 2 study of Infections, Pediatrics that has completed, run by Forest Laboratories. The registered enrollment target is 163 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT01400867, a Phase 2 study of Infections, Pediatrics, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 163 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a study of safety, effectiveness, blood levels and tolerance of Ceftaroline fosamil in children with skin infections receiving antibiotic therapy in the hospital.
Conditions Studied
Interventions
- DRUG Ceftaroline fosamil
- DRUG Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam
- DRUG Cephalexin or Clindamycin or Linezolid
Study Locations (20)
New York
- Investigational Site - Brooklyn - Brooklyn
- Investigational Site - New Hyde Park - New Hyde Park
- Investigational Site - Rochester - Rochester
- Investigational Site - Bronx - The Bronx
Ohio
- Investigational Site - Akron - Akron
- Investigational Site - Cleveland 1 - Cleveland
- Investigational Site - Cleveland 2 - Cleveland
- Investigational Site - Toledo - Toledo
Illinois
- Investigational Site - Chicago 1 - Chicago
- Investigational Site - Chicago 2 - Chicago
- Investigational Site - Springfield - Springfield
California
- Investigational Site - Orange - Orange
- Investigational Site - San Diego - San Diego
Arizona
- Investigational Site - Phoenix - Phoenix
Florida
- Investigational Site - Jacksonville - Jacksonville
Georgia
- Investigational Site - Atlanta - Atlanta
Louisiana
- Investigational Site - Shreveport - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01400867
The ClinicalTrials.gov registry entry for NCT01400867 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infections, Pediatrics appearing as the primary indexed condition, and to 3 interventions - of which Ceftaroline fosamil is the first listed.
NCT01400867 reports 20 study locations spanning 11 distinct geographic areas - top geographies include New York, Ohio, Illinois.
Frequently Asked Questions
What is clinical trial NCT01400867 about?
NCT01400867 is a clinical study titled "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections". This is a study of safety, effectiveness, blood levels and tolerance of Ceftaroline fosamil in children with skin infections receiving antibiotic therapy in the hospital.
What is the current status of trial NCT01400867?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 163 participants. The study started on 2011-12. Estimated completion is 2014-07.
What conditions does trial NCT01400867 study?
This clinical trial studies the following conditions: Infections, Pediatrics.
What interventions are being tested in trial NCT01400867?
The interventions under investigation include: Ceftaroline fosamil (DRUG), Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam (DRUG), Cephalexin or Clindamycin or Linezolid (DRUG).
Who is sponsoring clinical trial NCT01400867?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01400867 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.